Immune health grades: Finding resilience in the COVID-19 pandemic and beyond - 03/02/22
Doi : 10.1016/j.jaci.2021.10.025
Vincent C. Marconi, MD a, ⁎ 
, Venkatesh Krishnan, PhD b, E. Wesley Ely, MD, MPH c, d, Monty Montano, PhD e
, Venkatesh Krishnan, PhD b, E. Wesley Ely, MD, MPH c, d, Monty Montano, PhD e a Emory University School of Medicine and Rollins School of Public Health, Atlanta Veterans Affairs Medical Center, Atlanta, Ga
b Eli Lilly and Company, Indianapolis, Ind
c Critical Illness, Brain Dysfunction, and Survivorship Center, Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine at Vanderbilt University Medical Center, Nashville, Tenn
d Tennessee Valley Veteran’s Affairs Geriatric Research Education Clinical Center, Nashville, Tenn
e Harvard Medical School, Boston, Mass
∗Corresponding author: Vincent C. Marconi, MD, Emory University School of Medicine and Rollins School of Public Health, Atlanta Veterans Affairs Medical Center, 1760 Haygood Dr, NE, Atlanta, Georgia, 30322.Emory University School of Medicine and Rollins School of Public HealthAtlanta Veterans Affairs Medical Center1760 Haygood DrNEAtlantaGeorgia30322
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Key words : Immunologic resilience, COVID-19, aging, HIV, influenza
Le texte complet de cet article est disponible en PDF.
| Supported by the Emory Center for AIDS Research (grant P30AI050409 [to V.C.M.]), Boston Pepper Center (grant P30AG031679 [to M.M.]), and Harvard University Center for AIDS Research (grant P30AI060354 [to M.M.]). |
|
| Disclosure of potential conflict of interest: V. C. Marconi has received investigator-initiated research grants (to his institution) and consultation fees (both unrelated to the current work) from Eli Lilly, Bayer, Gilead Sciences, and ViiV Healthcare. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2021
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 149 - N° 2
P. 565-568 - février 2022 Retour au numéro
Article précédent
- Asthma and atopy in COVID-19: 2021 updates
- Tara F. Carr, Monica Kraft
- Advances in clinical outcomes: What we have learned during the COVID-19 pandemic
- Amer Al-Musa, Brenna LaBere, Saddiq Habiballah, Alan A. Nguyen, Janet Chou
Bienvenue sur EM-consulte, la référence des professionnels de santé.